Urine-based liquid biopsy for nonurological cancers

S Jain, SY Lin, W Song, YH Su - Genetic Testing and Molecular …, 2019 - liebertpub.com
S Jain, SY Lin, W Song, YH Su
Genetic Testing and Molecular Biomarkers, 2019liebertpub.com
Aims: The use of circulating cell-free DNA for detection of cancer genetics has been studied
extensively. Liquid biopsy often refers to the use of blood as a minimally invasive source of
body fluid for detecting circulating tumor DNA (ctDNA). However, urine collection, which is
completely noninvasive, has been shown to also have great promise to serve as an
alternate body fluid source for ctDNA. In this review article, we focus on the clinical utility of
urine for genetic liquid biopsy of nonurological cancers. Conclusion: Although still in early …
Aims: The use of circulating cell-free DNA for detection of cancer genetics has been studied extensively. Liquid biopsy often refers to the use of blood as a minimally invasive source of body fluid for detecting circulating tumor DNA (ctDNA). However, urine collection, which is completely noninvasive, has been shown to also have great promise to serve as an alternate body fluid source for ctDNA. In this review article, we focus on the clinical utility of urine for genetic liquid biopsy of nonurological cancers.
Conclusion: Although still in early stages as compared with blood-based liquid biopsy, recent studies have demonstrated the value of urine-based liquid biopsies for: nonurological cancer screening; early detection; monitoring for recurrence and metastasis; and therapeutic efficacy. Overall, the completely noninvasive and patient-friendly nature of the urine-based biopsy warrants further development and offers a promising alternative to blood-based biopsies.
Mary Ann Liebert